Advancing patient-centered care: progress and prospects of patient-reported outcomes in oncology clinical trials in China.
作者信息
Xie Zucheng, Tang Le, Shi Yuankai
机构信息
Department of Medical Oncology, Beijing Key Laboratory of Key Technologies for Early Clinical Trial Evaluation of Innovative Drugs for Major Diseases, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China.
出版信息
Lancet Reg Health West Pac. 2025 Jul 8;61:101630. doi: 10.1016/j.lanwpc.2025.101630. eCollection 2025 Aug.
Abstract
摘要
相似文献
1
Advancing patient-centered care: progress and prospects of patient-reported outcomes in oncology clinical trials in China.推进以患者为中心的医疗：中国肿瘤临床试验中患者报告结局的进展与前景
Lancet Reg Health West Pac. 2025 Jul 8;61:101630. doi: 10.1016/j.lanwpc.2025.101630. eCollection 2025 Aug.
2
Patient-centered perspectives: Examining quality-of-life integration in recent phase III lung cancer trials (2019-2023).以患者为中心的视角：审视2019 - 2023年近期III期肺癌试验中生活质量的纳入情况
J Cancer Policy. 2025 Jun;44:100566. doi: 10.1016/j.jcpo.2025.100566. Epub 2025 Mar 7.
3
The triad of excellence in oncology nursing: The synergy of clinical governance climate, digital health competence, and patient-centered care.肿瘤护理卓越的三元组：临床治理氛围、数字健康能力和以患者为中心的护理的协同作用。
Eur J Oncol Nurs. 2025 Aug 5;78:102956. doi: 10.1016/j.ejon.2025.102956.
4
Cultural and ethical barriers to implementing end-of-life advance care planning among oncology nursing professionals: a content analysis of open-ended questions.肿瘤护理专业人员实施临终预立医疗照护计划的文化和伦理障碍：对开放式问题的内容分析
BMC Med Ethics. 2025 Jul 11;26(1):96. doi: 10.1186/s12910-025-01261-x.
5
Family-centered interventions and patient outcomes in the adult intensive care unit: A systematic review of randomized controlled trials.以家庭为中心的干预措施与成人重症监护病房患者结局：一项随机对照试验的系统评价。
J Crit Care. 2024 Oct;83:154829. doi: 10.1016/j.jcrc.2024.154829. Epub 2024 May 17.
6
Patient-reported outcomes (PROs) in clinical trials and in clinical practice: report from the XXI national conference of the Italian Association of Medical Oncology (AIOM).临床试验和临床实践中的患者报告结局（PROs）：来自意大利医学肿瘤学会（AIOM）第21届全国会议的报告
BMJ Oncol. 2025 Jun 17;4(1):e000783. doi: 10.1136/bmjonc-2025-000783. eCollection 2025.
7
Communication Interventions Targeting Both Patients and Clinicians in Oncology: A Systematic Review of Randomized Controlled Trials.针对肿瘤学患者和临床医生的沟通干预措施：随机对照试验的系统评价
Psychooncology. 2025 Mar;34(3):e70108. doi: 10.1002/pon.70108.
8
Patient-centred care in precision oncology: A systematic review.精准肿瘤学中的以患者为中心的护理：一项系统综述。
Patient Educ Couns. 2025 Jul;136:108753. doi: 10.1016/j.pec.2025.108753. Epub 2025 Mar 12.
9
Patient-Centered Outpatient Process Optimization System Based on Intelligent Guidance in a Large Tertiary Hospital in China: Implementation Report.基于智能引导的中国大型三级医院以患者为中心的门诊流程优化系统：实施报告
JMIR Med Inform. 2025 Aug 29;13:e60219. doi: 10.2196/60219.
10
Global perspectives on patient-centered outcomes: advancing patient-centered cancer clinical trials globally.以患者为中心的结局的全球视角：在全球推进以患者为中心的癌症临床试验。
J Natl Cancer Inst Monogr. 2025 Mar 1;2025(68):35-41. doi: 10.1093/jncimonographs/lgae043.
本文引用的文献
1
ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0).欧洲肿瘤内科学会临床获益量表2.0版（ESMO-MCBS v2.0）
Ann Oncol. 2025 May 21. doi: 10.1016/j.annonc.2025.04.006.
2
Use of patient-reported outcomes to inform symptom and functional outcomes in cancer drug regulatory decisions: challenges and future directions.利用患者报告的结局来为癌症药物监管决策中的症状和功能结局提供信息：挑战与未来方向。
Lancet Oncol. 2025 Jun;26(6):664-666. doi: 10.1016/S1470-2045(25)00151-2. Epub 2025 Apr 14.
3
Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop.在癌症治疗的监管决策中使用患者报告的结局和健康相关生活质量数据：欧洲药品管理局-欧洲癌症研究与治疗组织研讨会要点
Lancet Oncol. 2025 Jun;26(6):687-690. doi: 10.1016/S1470-2045(25)00150-0. Epub 2025 Apr 14.
4
Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designs.提高癌症临床试验中患者报告结局测量的完成率：探索对试验设计影响的范围综述。
Eur J Cancer. 2024 Nov;212:114313. doi: 10.1016/j.ejca.2024.114313. Epub 2024 Sep 18.
5
Patient-reported outcomes for the phase 3 FURLONG study of furmonertinib versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic mutation-positive non-small cell lung cancer.呋喹替尼与吉非替尼作为中国局部晚期或转移性表皮生长因子受体（EGFR）突变阳性非小细胞肺癌患者一线治疗的3期FURLONG研究的患者报告结局。
Lancet Reg Health West Pac. 2024 Jun 17;48:101122. doi: 10.1016/j.lanwpc.2024.101122. eCollection 2024 Jul.
6
Application of Patient-Reported Outcome Measurements in Adult Tumor Clinical Trials in China: Cross-Sectional Study.患者报告结局测量在我国成人肿瘤临床试验中的应用：横断面研究。
J Med Internet Res. 2024 May 8;26:e45719. doi: 10.2196/45719.
7
Recommendations to address respondent burden associated with patient-reported outcome assessment.关于减轻与患者报告结局评估相关的应答负担的建议。
Nat Med. 2024 Mar;30(3):650-659. doi: 10.1038/s41591-024-02827-9. Epub 2024 Feb 29.
8
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures.设定癌症临床试验中分析患者报告结局和生活质量终点的国际标准——创新药物倡议（SISAQOL-IMI）：利益相关者的观点、目标和程序。
Lancet Oncol. 2023 Jun;24(6):e270-e283. doi: 10.1016/S1470-2045(23)00157-2.
9
Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group.肿瘤学试验中使用项目库进行患者报告结局测量的建议：一个国际多学科工作组的研究结果
Lancet Oncol. 2023 Feb;24(2):e86-e95. doi: 10.1016/S1470-2045(22)00654-4.
10
Application of Patient-Reported Outcome Measurements in Clinical Trials in China.患者报告结局测量在我国临床试验中的应用。
JAMA Netw Open. 2022 May 2;5(5):e2211644. doi: 10.1001/jamanetworkopen.2022.11644.
Zotero 插件